Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank100
Studio
Year-over-Year Change

Free cash flow yield

Latest
-1.68%
↑ 95% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-33.18%
Historical baseline
PeriodValueYoY Change
2025-1.68%+71.2%
2024-5.82%+86.8%
2023-43.95%-4.0%
2022-42.26%+76.9%
2021-182.55%-1223.2%
2020-13.80%-212.6%
2019-4.41%+63.5%
2018-12.09%-45.1%
2017-8.33%+50.8%
2016-16.94%-